Please login to the form below

Not currently logged in
Email:
Password:

Palantir Technologies

This page shows the latest Palantir Technologies news and features for those working in and with pharma, biotech and healthcare.

Merck forges cancer-focused big data alliance with Palantir

Merck forges cancer-focused big data alliance with Palantir

German drugmaker Merck KGaA took another step forward in its bid to become a digital health giant, inking a big data partnership with California's Palantir Technologies. ... Palantir contends that many scientists in pharma companies struggle with

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Latest Intelligence

  • Digital disruption Digital disruption

    An intelligent direction. Not quite halfway through 2017 and the year began with Merck KGaA inking a big data partnership with California’s Palantir Technologies that will harness advanced data analytics ... in which we are investing in a range of new

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Porterhouse Medical Group

The Porterhouse Medical Group provides market research, insights, and scientific and medical communication services to the pharmaceutical industry across the...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics